| Dr Sarah Grekin, MD | |
|
1380 Lusitana St Ste 412, Honolulu, HI 96813-2440 | |
| (808) 599-3780 | |
| (808) 538-1672 |
| Full Name | Dr Sarah Grekin |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 1380 Lusitana St Ste 412, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326205006 | NPI | - | NPPES |
| 8DL764 | Other | TX | BCBS (MDACC) |
| 304471101 (MDACC) | Medicaid | TX | |
| 4301091633 | Other | MI | LTD EDUC LICENSE |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dawson Dermatology Llc | 8224097894 | 3 |
News Archive
Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible.
If an earthquake hit tomorrow, would you be prepared? What would you do if a hurricane or wild fire was headed toward your community and you only had a few hours' notice to grab your belongings and evacuate? How would you handle situations like these with your children?
MabCure, N.V. ("MabCure") a wholly-owned subsidiary of MabCure Inc., a biotech company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has signed a clinical research agreement with the Ramathibodi Hospital, Mahidol University in Bangkok, Thailand.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The US Department of Defense (DOD) has awarded a $5 million grant to The Feinstein Institute for Medical Research and the University of Cincinnati to further develop a "lab-on-a-chip" device used for monitoring patients suffering from severe brain injury.
› Verified 9 days ago
| Entity Name | Dawson Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194885582 PECOS PAC ID: 8224097894 Enrollment ID: O20041008000302 |
News Archive
Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible.
If an earthquake hit tomorrow, would you be prepared? What would you do if a hurricane or wild fire was headed toward your community and you only had a few hours' notice to grab your belongings and evacuate? How would you handle situations like these with your children?
MabCure, N.V. ("MabCure") a wholly-owned subsidiary of MabCure Inc., a biotech company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has signed a clinical research agreement with the Ramathibodi Hospital, Mahidol University in Bangkok, Thailand.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The US Department of Defense (DOD) has awarded a $5 million grant to The Feinstein Institute for Medical Research and the University of Cincinnati to further develop a "lab-on-a-chip" device used for monitoring patients suffering from severe brain injury.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Grekin, MD 1380 Lusitana St Ste 412, Honolulu, HI 96813-2440 Ph: (808) 599-3780 | Dr Sarah Grekin, MD 1380 Lusitana St Ste 412, Honolulu, HI 96813-2440 Ph: (808) 599-3780 |
News Archive
Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible.
If an earthquake hit tomorrow, would you be prepared? What would you do if a hurricane or wild fire was headed toward your community and you only had a few hours' notice to grab your belongings and evacuate? How would you handle situations like these with your children?
MabCure, N.V. ("MabCure") a wholly-owned subsidiary of MabCure Inc., a biotech company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has signed a clinical research agreement with the Ramathibodi Hospital, Mahidol University in Bangkok, Thailand.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The US Department of Defense (DOD) has awarded a $5 million grant to The Feinstein Institute for Medical Research and the University of Cincinnati to further develop a "lab-on-a-chip" device used for monitoring patients suffering from severe brain injury.
› Verified 9 days ago
Dr. Jay L. Grekin, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4360 Fax: 808-522-3361 | |
Bradley S. Lau, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Geoffrey Strider Farnsworth, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Honolulu, HI 96819 Phone: 808-433-6661 | |
Dr. Linda E. Fancher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1010 S King St Ste 220, Honolulu, HI 96814 Phone: 808-597-8038 Fax: 808-596-2387 | |
Janice Matsunaga, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St, Suite 507, Honolulu, HI 96813 Phone: 808-532-0155 Fax: 808-532-0160 | |
Dr. Iris Kimhayoung Noh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4360 | |
Dylan Lee, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1380 Lusitana St Ste 401, Honolulu, HI 96813 Phone: 808-531-7541 Fax: 808-531-7542 |